Skip to content

Clinical trials

Observational Hematologic Neoplasms trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Observational Status: Unknown status Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20091
20132
20152
20161
20171
20186
20193
202011
20218
20225
20236
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status52

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris3
Dokuz Eylul University2
Fondazione del Piemonte per l'Oncologia2
Ospedale di Circolo - Fondazione Macchi2
Peking University People's Hospital2
University Hospital, Caen2
University of British Columbia2
Aalborg University Hospital1
Aga Khan University1
Assistance Publique Hopitaux De Marseille1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms52
Neoplasms7
COVID-194
Leukemia4
Bronchiolitis Obliterans Syndrome3
Drug-Related Side Effects and Adverse Reactions3
Atrial Fibrillation2
Hematologic Diseases2
Lymphoma2
Acute Kidney Injury1

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.